The Szilárd-Chalmers Reaction, discovered in 1934 by Leó Szilárd and Thomas A. Chalmers, is a nuclear chemistry phenomenon where neutron capture and gamma-ray emission cause a nucleus to recoil, breaking chemical bonds and enabling the separation of radioactive isotopes. This hot atom effect is key for producing high-specific-activity radioisotopes without carrier isotopes, used in medical and research applications.
Mechanism of the Szilárd-Chalmers Reaction
The reaction occurs when a nucleus in a molecule captures a neutron, forms an excited state, and emits gamma rays, imparting recoil energy that breaks chemical bonds.
- Neutron Capture: A stable isotope (e.g., 127I) absorbs a neutron, forming an excited nucleus:
127I + n → 128I*
- Gamma Emission and Recoil: The excited nucleus emits gamma rays, causing recoil that breaks bonds:
128I* → 128I + γ
- Chemical Separation: The radioactive atom (e.g., 128I) forms new compounds or ions, separable from the original molecule via chemical methods.
Recoil energy (tens to hundreds of eV) exceeds typical bond energies (1–10 eV), making the reaction effective in solids or liquids.

Key Features
Feature | Description |
---|---|
Nuclear Event | Neutron capture (n, γ) reaction on stable isotope atoms |
Outcome | Recoil-induced breaking of chemical bonds with the molecule |
Purpose | Separation and enrichment of radioactive isotopes |
Applications | Radiochemistry, tracer production, nuclear research |
Applications
The Szilárd-Chalmers Reaction is used to produce carrier-free radioisotopes for various applications:
Radioisotope Production:
- Medical Isotopes: 64Cu for PET imaging, 99Mo for technetium-99m, 142Pr for radiotherapy.
- Research: Trace analysis, e.g., 197Hg for biological matrices via radiochemical neutron activation analysis (RNAA).
- Industrial: Studying bond strengths in solids (e.g., chromium compounds).
Examples:
- Chlorine-38 from sodium chlorate, separated by precipitation.
- Iodine-131 from iodides for medical diagnostics.
Advantages and Limitations
Aspect | Advantages | Limitations |
---|---|---|
Efficiency | High enrichment factors; carrier-free isotopes. | 20–80% retention reduces yield; matrix-dependent. |
Scalability | Works with low neutron fluxes (e.g., reactors). | Requires chemical separation; radiation damage affects yields. |
Applications | Ideal for short-lived medical isotopes. | Less effective for gases; competing reactions complicate results. |
Recent Developments
As of 2025, research focuses on optimizing the reaction for clinical radionuclides like 198Au for no-carrier-added production. Advances in gamma-dose control and quantum modeling improve yields in complex matrices, enhancing applications in medical imaging and radiotherapy.